Semiconductor Maker GlobalFoundries Prices US$2.6 Billion IPO

Semiconductor manufacturer GlobalFoundries (Nasdaq: GFS) started publicly trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$2.6 billion.

The offering will be conducted through the issuance of 55.0 million common shares selling at US$47.00 per share. Out of this, around 30.25 million shares will be sold by the company while the remaining 24.75 million shares will be offered by the company’s existing stockholder, Mubadala Investment Company.

The company granted the underwriters a 30-day over-allotment option to purchase additional 8.25 million common shares at the same IPO price. Morgan Stanley, BofA Securities, J.P. Morgan, Citigroup, and Credit Suisse are all acting as bookrunners for the said offering.

The offering is expected to close on November 1, 2021, subject to customary closing conditions.

Based on its filing, the pricing values the company at roughly US$25.1 billion.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Related News

Robinhood’s IPO to be Priced at $38 Per Share

Robinhood’s IPO is expected to hit the Nasdaq today, but it appears that unenthusiastic demand...

Thursday, July 29, 2021, 09:00:00 AM

It’s Been A Painful Year For IPOs, Proceeds Are Down 93%

It hasn’t been a good year for companies going public  — uncertainty from mounting recession...

Monday, December 5, 2022, 03:06:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Gage Cannabis Expected To IPO On CSE In Early April

Gage Cannabis has reportedly filed for a direct listing in Canada. Reported this morning by...

Wednesday, March 24, 2021, 01:21:15 PM